A selective p53 activator and anticancer agent to improve colorectal cancer therapy
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma - ScienceDirect
Knockdown of p53 using siRNA and its effect on mouse ESC proliferation.... | Download Scientific Diagram
Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer - ScienceDirect
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program - ScienceDirect
Gain‐of‐function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells - Vaughan - 2017 - Molecular Oncology - Wiley Online Library
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome | Nature Communications
An in vivo genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer - Sultan - 2021 - Molecular Oncology - Wiley Online Library
Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion
Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion
A selective p53 activator and anticancer agent to improve colorectal cancer therapy - ScienceDirect
Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion
p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program - ScienceDirect
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer - ScienceDirect
Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode | Nature
Inducible Gene and shRNA Expression in Resident Hematopoietic Stem Cells In Vivo - Laurenti - 2010 - STEM CELLS - Wiley Online Library
Cancers | Free Full-Text | SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma | HTML
An unexpected role for p53 in regulating cancer cell–intrinsic PD-1 by acetylation | Science Advances
Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities | Nature Communications
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer - ScienceDirect
Ferroptosis as a p53-mediated activity during tumour suppression | Nature
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma - ScienceDirect
Loss of TP53 mediates suppression of Macrophage Effector Function via Extracellular Vesicles and PDL1 towards Resistance against Chemoimmunotherapy in B-cell malignancies | bioRxiv
